Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.
Russo E, Guy GW. Russo E, et al. Among authors: guy gw. Med Hypotheses. 2006;66(2):234-46. doi: 10.1016/j.mehy.2005.08.026. Epub 2005 Oct 4. Med Hypotheses. 2006. PMID: 16209908
A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers.
Stott C, White L, Wright S, Wilbraham D, Guy G. Stott C, et al. Springerplus. 2013 May 24;2(1):236. doi: 10.1186/2193-1801-2-236. Print 2013 Dec. Springerplus. 2013. PMID: 23750331 Free PMC article.
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Russo EB, Guy GW, Robson PJ. Russo EB, et al. Among authors: guy gw. Chem Biodivers. 2007 Aug;4(8):1729-43. doi: 10.1002/cbdv.200790150. Chem Biodivers. 2007. PMID: 17712817 Review.
Polypharmacology Shakes Hands with Complex Aetiopathology.
Brodie JS, Di Marzo V, Guy GW. Brodie JS, et al. Among authors: guy gw. Trends Pharmacol Sci. 2015 Dec;36(12):802-821. doi: 10.1016/j.tips.2015.08.010. Epub 2015 Oct 1. Trends Pharmacol Sci. 2015. PMID: 26434643
Cannabinoids and schizophrenia: therapeutic prospects.
Robson PJ, Guy GW, Di Marzo V. Robson PJ, et al. Among authors: guy gw. Curr Pharm Des. 2014;20(13):2194-204. doi: 10.2174/13816128113199990427. Curr Pharm Des. 2014. PMID: 23829368 Review.
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
Stott CG, White L, Wright S, Wilbraham D, Guy GW. Stott CG, et al. Among authors: guy gw. Eur J Clin Pharmacol. 2013 Apr;69(4):825-34. doi: 10.1007/s00228-012-1393-4. Epub 2012 Oct 4. Eur J Clin Pharmacol. 2013. PMID: 23052407 Clinical Trial.
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
Stott CG, White L, Wright S, Wilbraham D, Guy GW. Stott CG, et al. Among authors: guy gw. Eur J Clin Pharmacol. 2013 May;69(5):1135-47. doi: 10.1007/s00228-012-1441-0. Epub 2012 Nov 22. Eur J Clin Pharmacol. 2013. PMID: 23179176 Clinical Trial.
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.
Hilliard A, Stott C, Wright S, Guy G, Pryce G, Al-Izki S, Bolton C, Giovannoni G. Hilliard A, et al. ISRN Neurol. 2012;2012:802649. doi: 10.5402/2012/802649. Epub 2012 Aug 7. ISRN Neurol. 2012. PMID: 22928118 Free PMC article.
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.
McPartland JM, Guy GW, Di Marzo V. McPartland JM, et al. Among authors: guy gw. PLoS One. 2014 Mar 12;9(3):e89566. doi: 10.1371/journal.pone.0089566. eCollection 2014. PLoS One. 2014. PMID: 24622769 Free PMC article. Review.
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use.
Schoedel KA, Chen N, Hilliard A, White L, Stott C, Russo E, Wright S, Guy G, Romach MK, Sellers EM. Schoedel KA, et al. Hum Psychopharmacol. 2011 Apr;26(3):224-36. doi: 10.1002/hup.1196. Hum Psychopharmacol. 2011. PMID: 21671456 Clinical Trial.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback